相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advances in NK cell therapy for brain tumors
Jawad Fares et al.
NPJ PRECISION ONCOLOGY (2023)
Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study
Mohsen Sheykhhasan et al.
CANCER GENE THERAPY (2022)
GD2-CART cell therapy for H3K27M-mutated diffuse midline gliomas
Robbie G. Majzner et al.
NATURE (2022)
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia
Simona Caruso et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors
Francesco Boccalatte et al.
CANCERS (2022)
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery
Dalia Haydar et al.
NEURO-ONCOLOGY (2021)
T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic Challenges
Dalia Haydar et al.
FRONTIERS IN ONCOLOGY (2021)
Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma
Toshiro Hara et al.
CANCER CELL (2021)
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
Nicholas A. Vitanza et al.
NATURE MEDICINE (2021)
Evaluation and management of chimeric antigen receptor (CAR) T-cell-associated neurotoxicity
Luis Nicolas Gonzalez Castro et al.
NEURO-ONCOLOGY PRACTICE (2021)
Nusinersen Administration Via an Intrathecal Port in a 16-Year-Old Spinal Muscular Atrophy Patient with Profound Scoliosis
Marina Flotats-Bastardas et al.
PEDIATRIC NEUROSURGERY (2020)
Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors
Kevin Beccaria et al.
CANCER LETTERS (2020)
Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy
Cassie K. Chou et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Irradiated chimeric antigen receptor engineered NK-92MI cells show effective cytotoxicity against CD19+ malignancy in a mouse model
Qian Liu et al.
CYTOTHERAPY (2020)
CAR T Cell Therapy for Pediatric Brain Tumors
John D. Patterson et al.
FRONTIERS IN ONCOLOGY (2020)
The Glymphatic System and Waste Clearance with Brain Aging: A Review
Helene Benveniste et al.
GERONTOLOGY (2019)
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma
Stephanie L. Goff et al.
JOURNAL OF IMMUNOTHERAPY (2019)
Childhood brain tumors: current management, biological insights, and future directions
Ian F. Pollack et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2019)
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Kurt A. Schalper et al.
NATURE MEDICINE (2019)
Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis
Emma J. M. Grigor et al.
TRANSFUSION MEDICINE REVIEWS (2019)
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype
Darya Alizadeh et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Recent advances in the treatment of acute lymphoblastic leukemia
Hind Rafei et al.
LEUKEMIA & LYMPHOMA (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
CAR T cells for brain tumors: Lessons learned and road ahead
David Akhavan et al.
IMMUNOLOGICAL REVIEWS (2019)
Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma
Antonin Drean et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Single-Cell RNA Sequencing in Cancer: Lessons Learned and Emerging Challenges
Mario L. Suva et al.
MOLECULAR CELL (2019)
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al.
CLINICAL CANCER RESEARCH (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Decompressive craniectomy for acute ischemic stroke
Thomas Beez et al.
CRITICAL CARE (2019)
Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours
David T. W. Jones et al.
NATURE REVIEWS CANCER (2019)
CAR-Expressing Natural Killer Cells for Cancer Retargeting
Stephan Kloess et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2019)
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
Kevin Bielamowicz et al.
NEURO-ONCOLOGY (2018)
CD70, a novel target of CAR T-cell therapy for gliomas
Linchun Jin et al.
NEURO-ONCOLOGY (2018)
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
Christine E. Brown et al.
MOLECULAR THERAPY (2018)
Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
Christopher C. Kloss et al.
MOLECULAR THERAPY (2018)
The landscape of genomic alterations across childhood cancers
Susanne N. Groebner et al.
NATURE (2018)
IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
Keishi Adachi et al.
NATURE BIOTECHNOLOGY (2018)
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Li Tang et al.
NATURE BIOTECHNOLOGY (2018)
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells
Mara Vinci et al.
NATURE MEDICINE (2018)
A Combination of Ontogeny and CNS Environment Establishes Microglial Identity
F. Chris Bennett et al.
NEURON (2018)
A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy
Layton Lamsam et al.
NEUROSURGICAL FOCUS (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example
Hana Golan et al.
STEM CELL REPORTS (2018)
Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site
Manja Idorn et al.
CELLS (2018)
Role of the immunosuppressive microenvironment in immunotherapy
Garth W. Tormoen et al.
ADVANCES IN RADIATION ONCOLOGY (2018)
Microglia and macrophages in brain homeostasis and disease
Qingyun Li et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Precision Medicine in Pediatric Neurooncology: A Review
Aaron Y. Mochizuki et al.
ACS CHEMICAL NEUROSCIENCE (2018)
PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CAR
Elise A. Chong et al.
BLOOD (2017)
Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
Jiangtao Ren et al.
CLINICAL CANCER RESEARCH (2017)
Immunotherapy for Brain Tumors
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Survival rates and prognostic predictors of high grade brain stem gliomas in childhood: a systematic review and meta-analysis
Hadeel Hassan et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer
Amanda Rosewell Shaw et al.
MOLECULAR THERAPY (2017)
Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer
Somala Mohammed et al.
MOLECULAR THERAPY (2017)
The role of peripheral immune cells in the CNS in steady state and disease
Marco Prinz et al.
NATURE NEUROSCIENCE (2017)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
Thomas Shum et al.
CANCER DISCOVERY (2017)
Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients
Rui Liu et al.
ONCOTARGET (2017)
An oxygen sensitive self-decision making engineered CAR T-cell
Alexandre Juillerat et al.
SCIENTIFIC REPORTS (2017)
Targeting Malignant Brain Tumors with Antibodies
Rok Razpotnik et al.
FRONTIERS IN IMMUNOLOGY (2017)
Immunotherapy for Pediatric Brain Tumors
Elias J. Sayour et al.
BRAIN SCIENCES (2017)
Decompressive craniectomy for traumatic intracranial hypertension: application in children
Adam M. H. Young et al.
CHILDS NERVOUS SYSTEM (2017)
Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies
Jeong A. Park et al.
CANCER TREATMENT REVIEWS (2017)
Harnessing the Immunotherapy Revolution for the Treatment of Childhood Cancers
Robbie G. Majzner et al.
CANCER CELL (2017)
A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells
Sherly Mardiana et al.
CANCER RESEARCH (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
Intracranial pressure, its components and cerebrospinal fluid pressure-volume compensation
M. Kasprowicz et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
Ventricular access device placement in the fourth ventricle to treat malignant fourth ventricle brain tumors: technical note
David I. Sandberg et al.
CHILDS NERVOUS SYSTEM (2016)
Improving Care in Pediatric Neuro-oncology Patients: An Overview of the Unique Needs of Children With Brain Tumors
Cheryl Fischer et al.
JOURNAL OF CHILD NEUROLOGY (2016)
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
David A. Reardon et al.
CANCER IMMUNOLOGY RESEARCH (2016)
C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer
Moritz Rapp et al.
ONCOIMMUNOLOGY (2016)
Chimeric antigen receptor T cell therapy: 25 years in the making
Saar Gill et al.
BLOOD REVIEWS (2016)
CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients
Cameron J. Turtle et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape (Publication with Expression of Concern. See vol. 129, pg. 3464, 2019)
Meenakshi Hegde et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Chronic, intermittent convection-enhanced delivery devices
Owen Lewis et al.
JOURNAL OF NEUROSCIENCE METHODS (2016)
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
Hanren Dai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid
Christian Schlaeger et al.
NATURE (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
Lenka V. Hurton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
Hanren Dai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Targeting the tumor vasculature to enhance T cell activity
Evripidis Lanitis et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy
Raisa S. Pompe et al.
EUROPEAN JOURNAL OF CANCER (2015)
Consensus statement from the 2014 International Microdialysis Forum
Peter J. Hutchinson et al.
INTENSIVE CARE MEDICINE (2015)
An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells
Shigeki Yagyu et al.
MOLECULAR THERAPY (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
Ignazio Caruana et al.
NATURE MEDICINE (2015)
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
Adrienne H. Long et al.
NATURE MEDICINE (2015)
Convection-Enhanced Drug Delivery to the Brain: Therapeutic Potential and Neuropathological Considerations
Neil U. Barua et al.
BRAIN PATHOLOGY (2014)
Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience
Francesco Motta et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Safety Profile of Long-Term Intraventricular Access Devices in Pediatric Patients Receiving Radioimmunotherapy for Central Nervous System Malignancies
Kim Kramer et al.
PEDIATRIC BLOOD & CANCER (2014)
Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
Liang-Chuan S. Wang et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Going viral with cancer immunotherapy
Brian D. Lichty et al.
NATURE REVIEWS CANCER (2014)
IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
Nicoletta Cieri et al.
BLOOD (2013)
Tumor-Infiltrating Lymphocytes in Glioblastoma Are Associated with Specific Genomic Alterations and Related to Transcriptional Class
W. Caleb Rutledge et al.
CLINICAL CANCER RESEARCH (2013)
Intermittent convection-enhanced delivery to the brain through a novel transcutaneous bone-anchored port
N. U. Barua et al.
JOURNAL OF NEUROSCIENCE METHODS (2013)
Decompressive craniectomy: past, present and future
Angelos G. Kolias et al.
NATURE REVIEWS NEUROLOGY (2013)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
Local Delivery of Interleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice
Dhanalakshmi Chinnasamy et al.
CLINICAL CANCER RESEARCH (2012)
Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
Richard A. Morgan et al.
HUMAN GENE THERAPY (2012)
Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas
Gordon Li et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
The Pediatric Cancer Genome Project
James R. Downing et al.
NATURE GENETICS (2012)
Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology
Arnold B. Etame et al.
NEUROSURGICAL FOCUS (2012)
Capture, crawl, cross: the T cell code to breach the blood-brain barriers
Britta Engelhardt et al.
TRENDS IN IMMUNOLOGY (2012)
Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
Edmund K. Moon et al.
CLINICAL CANCER RESEARCH (2011)
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients
Barbara Savoldo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Bahareh Ajami et al.
NATURE NEUROSCIENCE (2011)
Trafficking of immune cells in the central nervous system
Emma H. Wilson et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
Intracranial volume, brain volume, reserve volume and morphological signs of increased intracranial pressure – A post-mortem analysis
H. Maxeiner et al.
Legal Medicine (2008)
Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system
Romain Cayrol et al.
NATURE IMMUNOLOGY (2008)
An antigen-specific pathway for CD8 T cells across the blood-brain barrier
Ian Galea et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4(+) T cell compartment without affecting regulatory T-cell function
Peter E. Fecci et al.
CLINICAL CANCER RESEARCH (2007)
Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cells
A. Loskog et al.
LEUKEMIA (2006)
Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-β production
S Dohgu et al.
BRAIN RESEARCH (2005)
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
C Imai et al.
LEUKEMIA (2004)
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor
J Maher et al.
NATURE BIOTECHNOLOGY (2002)
分享论文
